[1. Sękowska A, Gospodarek E, Kusza K. The prevalence of infections and colonisation with Klebsiella pneumoniae strains isolated in ICU patients. Anaesthesiol Intensive Ther. 2014;46:280-283.10.5603/AIT.2014.0045]Search in Google Scholar
[2. Różańska A, Bulanda M. Demographic characteristics of patients and their assessment of selected hygienic practices of hospital personnel in the context of safety climate of hospitalization. Am J Infect Control. 2015;43:354-357.10.1016/j.ajic.2014.12.022]Search in Google Scholar
[3. Singh S, Goyal R, Ramesh GS, et al. Control of hospital acquired infections in the ICU: A service perspective. Med Journal Armed Forces India. 2015;71:28-32.10.1016/j.mjafi.2014.08.008]Search in Google Scholar
[4. Sevransky JE, Martin GS, Shanholtz C, et al. Mortality in sepsis versus non-sepsis induced acute lung injury. Crit Care. 2009;13:R150.10.1186/cc8048]Search in Google Scholar
[5. Coelho FR, Martins JO. Diagnostic methods in sepsis: the need of speed. Rev Assoc Med Bras. 2012;58:498-504.10.1590/S0104-42302012000400024]Search in Google Scholar
[6. Singh S, Chaturvedi R, Garg SM, Datta R, Kumar A. Incidence of healthcare associated infection in the surgical ICU of a tertiary care hospital. Med Journal Armed Forces India. 2013;69:124-129.10.1016/j.mjafi.2012.08.028]Search in Google Scholar
[7. Dereli N, Ozayar E, Degerli S, Sahin S, Koç F. Three-Year Evaluation of Nosocomial Infection Rates of the ICU. Rev Bras Anestesiol. 2013;63:73-84.10.1016/S0034-7094(13)70199-5]Search in Google Scholar
[8. Harwan WA, Abbassi MM, El-Attar MM, Farid SF. Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital. Bull Fac Pharmacy. 2014;52:135-144.10.1016/j.bfopcu.2014.04.001]Search in Google Scholar
[9. Scherbaum M, Kösters K, Mürbeth RE, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect Dis. 2014;14:124.10.1186/1471-2334-14-124394398724592922]Search in Google Scholar
[10. Guggenbichler J, Assadian O, Kramer M. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters , ventilator-associated pneumonia , urinary tract infections. GMS Krankenhhyg Interdiszip. 2011;6:1-19.]Search in Google Scholar
[11. McDonald CI, Fung YL, Shekar K, et al. The impact of acute lung injury, ECMO and transfusion on oxidative stress and plasma selenium levels in an ovine model. J Trace Elem Med Biol. 2015;30:4-10.10.1016/j.jtemb.2015.01.00425744503]Search in Google Scholar
[12. Mérens A, Delacour H, Plésiat P, Cavallo J-D, Jeannot K. Pseudomonas aeruginosa et résistance aux antibiotiques. Rev Francoph des Lab. 2011;2011:49-62.10.1016/S1773-035X(11)71102-9]Search in Google Scholar
[13. Mahafza T, Batarseh S, Bsoul N. Early vs. late tracheostomy for the ICU patients: Experience in a referral hospital. Saudi J Anaesth. 2012;6:152-154.10.4103/1658-354X.97029338525822754442]Search in Google Scholar
[14. Juayang AC, Jr DGM, Reyes GBDL, Acosido MAD, Gallega CT. Review on the Antimicrobial Resistance of Pathogens from Tracheal and Endotracheal Aspirates of Patients with Clinical Manifestations of Pneumonia in Bacolod City in 2013. International Journal of Bacteriology. 2015;2015.10.1155/2015/942509474548026904750]Search in Google Scholar
[15. Gupta A, Ampofo K, Rubenstein D, Saiman L. Extended spectrum beta lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol. 2003;23:439-443.10.1038/sj.jp.721097313679928]Search in Google Scholar
[16. Shigemoto N, Kayama S, Kuwahara R, et al. A novel metallo-β- lactamase, IMP-34, in Klebsiella isolates with decreased resistance to imipenem. Diagn Microbiol Infect Dis. 2013;76:119-121.10.1016/j.diagmicrobio.2013.02.03023541689]Search in Google Scholar
[17. Charrouf FO, Hamze M, Mallat H, Achkar M, Dabboussia F. Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon. Médecine Mal Infect. 2014;44:535-538.10.1016/j.medmal.2014.10.00125453362]Search in Google Scholar
[18. Murray CK, Hospenthal DR. Acinetobacter infection in the ICU. Crit Care Clin. 2008;24:237-248.10.1016/j.ccc.2007.12.00518361943]Search in Google Scholar
[19. Vourli S, Frantzeskaki F, Meletiadis J, et al. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients. Int J Antimicrob Agents. 2015;45:670-671.10.1016/j.ijantimicag.2015.02.00525795317]Search in Google Scholar
[20. Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, et al. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Int J Antimicrob Agents. 2004;23:487-493.10.1016/j.ijantimicag.2003.09.02615120728]Search in Google Scholar
[21. Lesho E, Wortmann G, Moran K, Craft D. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility. Clin Infect Dis. 2005;41:758-759.10.1086/43262316080102]Search in Google Scholar
[22. Ikonomidis A, Pournaras S, Maniatis AN, Legakis NJ, Tsakris A. Discordance of meropenem versus imipenem activity against Acinetobacter baumannii. Int J Antimicrob Agents. 2015;28:376-377.10.1016/j.ijantimicag.2006.07.007]Search in Google Scholar
[23. Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother. 2005;49:1337-1339.10.1128/AAC.49.4.1337-1339.2005]Search in Google Scholar
[24. Wood GC, Hanes SD, Croce M a, Fabian TC, Boucher B a. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis. 2002;34:1425-1430.10.1086/340055]Search in Google Scholar
[25. Yang Q, Zhang H, Cheng J, et al. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Int J Antimicrob Agents. 2015;45:485-490.10.1016/j.ijantimicag.2014.11.012]Search in Google Scholar
[26. Kanayama A, Kobayashi I, Shibuya K. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan. Int J Antimicrob Agents. 2015;45:113-118.10.1016/j.ijantimicag.2014.06.005]Search in Google Scholar
[27. Dzutsev A, Trinchieri G. Proteus mirabilis: The Enemy Within. Immunity. 2015;42:602-604.10.1016/j.immuni.2015.04.004]Search in Google Scholar
[28. O’Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13:534-546.10.1128/CMR.13.4.534]Search in Google Scholar
[29. Nijssen S, Florijn A, Bonten MJM, et al. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2015;24:585-591.10.1016/j.ijantimicag.2004.08.008]Search in Google Scholar
[30. De Champs C, Bonnet R, Sirot D, Chanal C, Sirot J. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemother. 2000;45:537-539.10.1093/jac/45.4.537]Search in Google Scholar
[31. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2015;47:273-295. 10.1016/S0163-4453(03)00096-3]Search in Google Scholar
[32. Hofmann A, Sommer R, Hauck D, et al. Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa. Carbohydr Res. 2015;412:34-42.10.1016/j.carres.2015.04.010]Search in Google Scholar
[33. Sahner JH, Empting M, Kamal A, et al. Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa. Eur J Med Chem. 2015;96:14-21.10.1016/j.ejmech.2015.04.007]Search in Google Scholar
[34. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568-585.10.1016/j.ijantimicag.2015.03.001]Search in Google Scholar
[35. Michalopoulos a. S, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: The renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11:115-121.10.1111/j.1469-0691.2004.01043.x]Search in Google Scholar
[36. Frédéric G, Julien T, Benoit R, et al. Selective digestive decontamination and empirical antimicrobial therapy of late - Onset ventilator - Associated pneumonia in trauma patients. J Acute Dis. 2012;1:1-6.10.1016/S2221-6189(13)60001-3]Search in Google Scholar
[37. Cohen MJ, Block CS, Moses AE, Nir-Paz R. Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance. Clin Microbiol Infect. 2014;20:O188-196.10.1111/1469-0691.12362]Search in Google Scholar
[38. Van der Wolf PJ, Rothkamp A, Junker K, de Neeling AJ. Staphylococcus aureus (MSSA) and MRSA (CC398) isolated from post-mortem samples from pigs. Vet Microbiol. 2012;158(1-2):136-141.10.1016/j.vetmic.2012.01.025]Search in Google Scholar
[39. Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect. 2011;17:1581-1586.]Search in Google Scholar
[40. Patel H, Nguyen GC. S1103 Association of Methicillin-Resistant Staph Aureus (MRSA) with Higher Mortality Among Hospitalized IBD Patients. Gastroenterology. 2009;136:A - 189.10.1016/S0016-5085(09)60852-0]Search in Google Scholar
[41. Köck R, Winner K, Schaumburg F, et al. Admission prevalence and acquisition of nasal carriage of meticillin-resistant Staphylococcus aureus (MRSA) in German rehabilitation centres. J Hosp Infect. 2014;87:115-118.10.1016/j.jhin.2014.02.00724792577]Search in Google Scholar
[42. González-Domínguez M, Seral C, Sáenz Y, et al. Epidemiological features, resistance genes, and clones among community-onset methicillinresistant Staphylococcus aureus (CO-MRSA) isolates detected in northern Spain. Int J Med Microbiol. 2012;302:320-326.10.1016/j.ijmm.2012.10.00323177275]Search in Google Scholar
[43. Goodwin KD, McNay M, Cao Y, et al. A multi-beach study of Staphylococcus aureus, MRSA, and enterococci in seawater and beach sand. Water Res. 2012;46:4195-4207.10.1016/j.watres.2012.04.001]Search in Google Scholar
[44. Rao N, Bennett JE. Eradication of methicillin resistant Staph aureus (MRSA) with ciprofloxacin. Am J Infect Control. 1989;17:117.10.1016/0196-6553(89)90116-8]Search in Google Scholar
[45. Chang Y-Y, Chuang Y-C, Siu LK, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48:219-225.10.1016/j.jmii.2014.05.01025074627]Search in Google Scholar
[46. Jana M, Misra AK. Synthesis of trisaccharide and a tetrasaccharide repeating unit corresponding to the O-antigen of Shiga toxin producing Escherichia coli O177. Tetrahedron. 2015;71:3960-3965.10.1016/j.tet.2015.04.042]Search in Google Scholar
[47. Magdy A, Elhadidy M, Abd Ellatif ME, et al. Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study. Int J Surg. 2015;18:169-173.10.1016/j.ijsu.2015.04.07725937151]Search in Google Scholar
[48. Perepelov A V, Wang Q, Senchenkova SN, et al. Structure and gene cluster of the O-antigen of Escherichia coli O140. Carbohydr Res. 2015;411:33-36.10.1016/j.carres.2015.04.00425965146]Search in Google Scholar
[49. Zdorovenko EL, Golomidova AK, Prokhorov NS, et al. Structure of the O-polysaccharide of Escherichia coli O87. Carbohydr Res. 2015;412:15-18.10.1016/j.carres.2015.04.01425988496]Search in Google Scholar
[50. Giakkoupi P, Tryfinopoulou K, Polemis M, et al. Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area. Diagn Microbiol Infect Dis. 2015;82:62-64.10.1016/j.diagmicrobio.2015.02.00925752202]Search in Google Scholar
[51. Mahrouki S, Chihi H, Bourouis A, et al. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6’)-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn Microbiol Infect Dis. 2015;81:50-52.10.1016/j.diagmicrobio.2014.09.02125315769]Search in Google Scholar
[52. Ovchinnikova OG, Moryl M, Shashkov AS, Chizhov AO, et al. Structure of the O-polysaccharide of Providencia alcalifaciens O2 containing ascarylose and N-(L-alanyl)-D-glucosamine. Carbohydr Res. 2015;401:11-15.10.1016/j.carres.2014.10.01625464076]Search in Google Scholar
[53. Luzzaro F, Mezzatesta M, Mugnaioli C, et al. Trends in production of extended-spectrum - β-lactamases among enterobacteria of medical interest: Report of the second Italian nationwide survey. J Clin Microbiol. 2006;44:1659-1664. 10.1128/JCM.44.5.1659-1664.2006147920716672390]Search in Google Scholar